DelMar Pharmaceuticals’ Acquisition of Adgero Biopharmaceuticals

Ambrogio Visconti North America, North America Legal Chronicle

Lowenstein Sandler LLP represented DelMar Pharmaceuticals in the transaction. DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) and Adgero Biopharmaceuticals Holdings, Inc. have entered into a definitive merger agreement…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Ambrogio Visconti

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here